Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors
Richard Riedel(University of Cologne), Jana Fassunke(University of Cologne), Hannah L. Tumbrink(University of Cologne), Andreas H. Scheel(University of Cologne), Carina Heydt(University of Cologne), Lena Hieggelke(University of Cologne), Matthias Scheffler(University of Cologne), Alena Heimsoeth(University of Cologne), Lucia Nogová(University of Cologne), Sebastian Michels(University of Cologne), Jan-Phillip Weber(University of Cologne), Rieke Fischer(University of Cologne), Anna Eisert(University of Cologne), Theresa Westphal(University of Cologne), Diana Schaufler(University of Cologne), Janna Siemanowski(University of Cologne), Michaela A. Ihle(University of Cologne), Svenja Wagener‐Ryczek(University of Cologne), Roberta Castiglione(Klinikum Stuttgart), Roberto Pappesch(University of Cologne), Jan Rehker(University of Cologne), Jessica Jürgens(Witten/Herdecke University), Erich Stoelben(Witten/Herdecke University), Anne Bunck(University of Cologne), Carsten Kobe(University of Cologne), Sabine Merkelbach‐Bruse(University of Cologne), Martin L. Sos(University of Cologne), Reinhard Büttner(University of Cologne), Jürgen Wolf(University of Cologne)
Cited by 29
Abstract
Related Papers
No related papers found
Powered by citation graph analysis